other material
confidence high
sentiment positive
materiality 0.55
Bio-Rad authorizes new $500M share repurchase program, superseding prior $650M program
BIO-RAD LABORATORIES, INC.
- Board authorized up to $500M in common stock repurchases; no time limit.
- Prior $650M repurchase program was completed on June 5, 2023.
- Repurchases at management's discretion on open market or privately.
- Acquired shares for employee stock plans, acquisitions, and dilution offset.